526 related articles for article (PubMed ID: 25475434)
1. Semaphorin3a promotes advanced diabetic nephropathy.
Aggarwal PK; Veron D; Thomas DB; Siegel D; Moeckel G; Kashgarian M; Tufro A
Diabetes; 2015 May; 64(5):1743-59. PubMed ID: 25475434
[TBL] [Abstract][Full Text] [Related]
2. Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1-nephrin interaction.
Reidy KJ; Aggarwal PK; Jimenez JJ; Thomas DB; Veron D; Tufro A
Am J Pathol; 2013 Oct; 183(4):1156-1168. PubMed ID: 23954273
[TBL] [Abstract][Full Text] [Related]
3. Podocyte-specific VEGF-a gain of function induces nodular glomerulosclerosis in eNOS null mice.
Veron D; Aggarwal PK; Velazquez H; Kashgarian M; Moeckel G; Tufro A
J Am Soc Nephrol; 2014 Aug; 25(8):1814-24. PubMed ID: 24578128
[TBL] [Abstract][Full Text] [Related]
4. Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.
Veron D; Bertuccio CA; Marlier A; Reidy K; Garcia AM; Jimenez J; Velazquez H; Kashgarian M; Moeckel GW; Tufro A
Diabetologia; 2011 May; 54(5):1227-41. PubMed ID: 21318407
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin3a signaling, podocyte shape, and glomerular disease.
Tufro A
Pediatr Nephrol; 2014 Apr; 29(4):751-5. PubMed ID: 24464477
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin3a regulates endothelial cell number and podocyte differentiation during glomerular development.
Reidy KJ; Villegas G; Teichman J; Veron D; Shen W; Jimenez J; Thomas D; Tufro A
Development; 2009 Dec; 136(23):3979-89. PubMed ID: 19906865
[TBL] [Abstract][Full Text] [Related]
7. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
[TBL] [Abstract][Full Text] [Related]
8. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
9. Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in mice.
Mohamed R; Ranganathan P; Jayakumar C; Nauta FL; Gansevoort RT; Weintraub NL; Brands M; Ramesh G
J Mol Med (Berl); 2014 Dec; 92(12):1245-56. PubMed ID: 25249008
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
11. Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy.
Lin J; Shi Y; Peng H; Shen X; Thomas S; Wang Y; Truong LD; Dryer SE; Hu Z; Xu J
J Pathol; 2015 May; 236(1):30-40. PubMed ID: 25641678
[TBL] [Abstract][Full Text] [Related]
12. CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes.
Teng B; Schroder P; Müller-Deile J; Schenk H; Staggs L; Tossidou I; Dikic I; Haller H; Schiffer M
Diabetes; 2016 Dec; 65(12):3667-3679. PubMed ID: 27531950
[TBL] [Abstract][Full Text] [Related]
13. Podocyte apoptosis in diabetic nephropathy by BASP1 activation of the p53 pathway via WT1.
Zhang Y; Xu C; Ye Q; Tong L; Jiang H; Zhu X; Huang L; Lin W; Fu H; Wang J; Persson PB; Lai EY; Mao J
Acta Physiol (Oxf); 2021 May; 232(1):e13634. PubMed ID: 33615732
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
15. Semaphorin3A-Inhibitor Ameliorates Doxorubicin-Induced Podocyte Injury.
Sang Y; Tsuji K; Inoue-Torii A; Fukushima K; Kitamura S; Wada J
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521824
[TBL] [Abstract][Full Text] [Related]
16. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
17. WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy.
Wan J; Hou X; Zhou Z; Geng J; Tian J; Bai X; Nie J
Free Radic Biol Med; 2017 Jul; 108():280-299. PubMed ID: 28315733
[TBL] [Abstract][Full Text] [Related]
18. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
19. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
[TBL] [Abstract][Full Text] [Related]
20. KCNQ1OT1 inhibition alleviates high glucose-induced podocyte injury by adsorbing miR-23b-3p and regulating Sema3A.
Fei B; Zhou H; He Z; Wang S
Clin Exp Nephrol; 2022 May; 26(5):385-397. PubMed ID: 34997887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]